10.25673/120590">
Proceedings of International Conference on Applied Innovation in IT  ·  2025/06/27  ·  Vol. 13  ·  Issue 2  ·  pp. 705–711
Evaluation of Interferon-Gamma, Vitamin E, and Electrolytes (Sodium, Potassium, Chloride) Levels as Potential Biomarkers in Iraqi Breast Cancer Women
Muqdad Khamis Abd, Abdulsalam Tawfeeq Salih Alsamarai and Ahmed Zuhair Alsammarraie
📄 Download PDF DOI: <a href="http://dx.doi.org/10.25673/120590">10.25673/120590</a>
Abstract
The primary objective of this study is to evaluate the potential of interferon-gamma, vitamin E, and electrolyte levels (sodium, potassium, and chloride) as biomarkers for breast cancer diagnosis. Patients and Methods: This study was conducted at the Oncology Teaching Hospital, Medical City, Baghdad, and included 130 female participants who ranged in age from 30 to 71 years. The blood samples were collected between May 13, 2024, and August 11, 2024.Methods: The levels of interferon-gamma, vitamin E, and electrolytes (sodium, potassium, chloride) were measured in the serum of the participants using appropriate laboratory techniques. The data obtained were then analyzed to identify any significant differences among the three groups. The results demonstrated that interferon-gamma levels were significantly elevated in both the newly diagnosed group (G1) and the chemotherapy-treated group (G2) when compared to the control group (C). Additionally, a decrease in vitamin E levels was observed in the newly diagnosed group (G1) compared to the treated group (G2) and the control group (C). The electrolyte analysis revealed a significant reduction in sodium and chloride levels in the newly diagnosed group (G1) compared to the other two groups, while potassium levels were significantly elevated in the newly diagnosed group (G1) compared to both the treated and control groups Furthermore, the ROC analysis showed that interferon-gamma (IFN-γ) demonstrated high sensitivity (93.33%) and specificity (62.50%), making it a strong marker for cancer detection. Sodium (Na) exhibited exceptional diagnostic performance with 100% sensitivity and specificity. Similarly, chloride (Cl) showed excellent results, with 100% sensitivity and 88.89% specificity. In contrast, vitamin E exhibited lower sensitivity (51.11%) but demonstrated high specificity (92.50%). The findings suggest that interferon-gamma, vitamin E, and electrolyte levels, specifically sodium, potassium, and chloride, could be significant biomarkers for differentiating between newly diagnosed breast cancer patients and healthy individuals.
Keywords
Breast Cancer Interferon-Gamma Vitamin E Sodium Potassium Chloride.
References
  1. H. K. Matthews, C. Bertoli, and R. A. M. de Bruin, "Cell cycle control in cancer," Nature Reviews Molecular Cell Biology, vol. 23, no. 1, pp. 74–88, Sep. 2021, doi: 10.1038/s41580-021-00404-3.
  2. M. K. Abd, A. T. S. Alsamarai, and A. Q. M. A-Qader, "Evaluation the level of Interleukin-6 and total protein levels on women with breast cancer," AIP Conf. Proc., vol. 2450, no. 1, Jul. 2022, doi: 10.1063/5.0094134/2823930.
  3. A. N. Giaquinto, K. D. Miller, K. Y. Tossas, R. A. Winn, A. Jemal, and R. L. Siegel, "Cancer statistics for African American/Black People 2022," CA Cancer J. Clin., vol. 72, no. 3, pp. 202–229, May 2022, doi: 10.3322/caac.21718.
  4. C. S. Yang, P. Luo, Z. Zeng, H. Wang, M. Malafa, and N. Suh, "Vitamin E and cancer prevention: Studies with different forms of tocopherols and tocotrienols," Mol. Carcinog., vol. 59, no. 4, pp. 365–389, Apr. 2020, doi: 10.1002/mc.23160.
  5. J. Delattre, J.-L. Beaudeux, and D. Bonnefont-Rousselot, Radicaux libres et stress oxydant (aspects biologiques et pathologiques). Paris: Editions Tec & Doc, 2005.
  6. H. Ding, G. Wang, Z. Yu, H. Sun, and L. Wang, "Role of interferon-gamma (IFN-γ) and IFN-γ receptor 1/2 (IFNγR1/2) in regulation of immunity, infection, and cancer development: IFN-γ-dependent or independent pathway," Biomed. Pharmacother., vol. 155, p. 113683, Nov. 2022, doi: 10.1016/j.biopha.2022.113683.
  7. D. Jorgovanovic, M. Song, L. Wang, and Y. Zhang, "Roles of IFN-γ in tumor progression and regression: a review," Biomark. Res., vol. 8, no. 1, pp. 1–16, Sep. 2020, doi: 10.1186/s40364-020-00228-x.
  8. E. F. Wheelock, "Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin," Science, vol. 149, no. 3681, pp. 310–311, Jul. 1965, doi: 10.1126/science.149.3681.310.
  9. H. Raftopoulos, "Diagnosis and management of hyponatremia in cancer patients," Support. Care Cancer, vol. 15, no. 12, pp. 1341–1347, Dec. 2007, doi: 10.1007/s00520-007-0309-9.
  10. R. Ouwerkerk, M. A. Jacobs, K. J. Macura, A. C. Wolff, V. Stearns, S. D. Mezban, N. F. Khouri, D. A. Bluemke, and P. A. Bottomley, "Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI," Breast Cancer Res. Treat., vol. 106, pp. 151–160, Dec. 2007.
  11. A. Guyton, Textbook of Medical Physiology, 11th ed. Philadelphia, PA, USA: Elsevier, 2006. [Online]. Available: https://www.academia.edu/download/48363656/Fiziologie-Guyton-ed11.pdf. Accessed: Mar. 29, 2025.
  12. A. Rashidi, N. Youssef, B. Workeneh, A. Carsel, V. Gutgarts, and S. Latcha, "Electrolytes abnormalities in cancer patients," Am. J. Nephrol., pp. 1–20, Feb. 2025, doi: 10.1159/000544877.
  13. S. Puri et al., "Prediction of chemotherapy-induced nausea and vomiting from patient-reported and genetic risk factors," Support. Care Cancer, vol. 26, no. 8, pp. 2911–2918, Aug. 2018, doi: 10.1007/s00520-018-4120-6.
  14. C. Abiaka et al., "Plasma concentrations of alpha-tocopherol and urate in patients with different types of cancer," J. Clin. Pharm. Ther., vol. 26, no. 4, pp. 265–270, Aug. 2001, doi: 10.1046/j.1365-2710.2001.00350.x.
  15. M. Torun, S. Yardim, A. Gönenç, H. Sargin, A. Menevse, and B. Simsek, "Serum β–carotene, vitamin E, vitamin C and malondialdehyde levels in several types of cancer," J. Clin. Pharm. Ther., vol. 20, no. 5, pp. 259–263, Oct. 1995, doi: 10.1111/j.1365-2710.1995.tb00660.x.
  16. W. K. Al Dleemy, "Effect of some antioxidant parameters in breast cancer," Tikrit J. Pure Sci., vol. 14, no. 2, pp. 46–50, 2009.
  17. M. Gerber, S. Richardson, R. Salkeld, and P. Chappuis, "Antioxidants in female breast cancer patients," Cancer Invest., vol. 9, no. 4, pp. 421–428, 1991, doi: 10.3109/07357909109084640.
  18. H. Kasai, "Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis," Mutat. Res. Rev. Mutat. Res., vol. 387, no. 3, pp. 147–163, Dec. 1997, doi: 10.1016/s1383-5742(97)00035-5.
  19. M. De La Fuente, M. Carazo, R. Correa, and M. Del Rio, "Changes in macrophage and lymphocyte functions in guinea-pigs after different amounts of vitamin E ingestion," Br. J. Nutr., vol. 84, no. 1, pp. 25–29, 2000, doi: 10.1017/s0007114500001197.
  20. S. E. Fenton, D. Saleiro, and L. C. Platanias, "Type I and II interferons in the anti-tumor immune response," Cancers, vol. 13, no. 5, p. 1037, Mar. 2021, doi: 10.3390/cancers13051037.
  21. H. N. E. Mohammed and A. A. Mohammed, "Determination of interferon gamma protein in serum of breast cancer patients using the ELISA," J. Appl. Sci. Nanotechnol., vol. 2, no. 1, pp. 37–48, Dec. 2021.
  22. S. E. Fenton, D. Saleiro, and L. C. Platanias, "Type I and II interferons in the anti-tumor immune response," Cancers, vol. 13, no. 5, p. 1037, Mar. 2021, doi: 10.3390/cancers13051037.
  23. A. Nicolini, A. Carpi, and G. Rossi, "Cytokines in breast cancer," Cytokine Growth Factor Rev., vol. 17, no. 5, pp. 325–337, Oct. 2006, doi: 10.1016/j.cytogfr.2006.07.002.
  24. G. Q. Chanihoon et al., "An AAS dependent method for quantitative analysis of essential trace elements from blood samples of Pakistani female breast cancer patients," Adv. Breast Cancer Res., vol. 10, no. 3, pp. 44–59, Jun. 2021, doi: 10.4236/abcr.2021.103004.
  25. A. Yousif, P. Ismail, and N. A. Ismail, "Steroid hormones, immunoglobulins and some biochemical parameters changes in patients with breast cancer," Diyala J. Med., vol. 1, no. 1, 2016.
  26. B. Fibbi et al., "Hyponatremia and cancer: From bedside to benchside," Cancers (Basel), vol. 15, no. 4, p. 1197, Feb. 2023, doi: 10.3390/cancers15041197.
  27. T. Clausen and M. E. Everts, "Regulation of the Na,K-pump in skeletal muscle," Kidney Int., vol. 35, no. 1, pp. 1–13, 1989, doi: 10.1038/ki.1989.1.
  28. R. Berardi, M. Torniai, E. Lenci, F. Pecci, F. Morgese, and S. Rinaldi, "Electrolyte disorders in cancer patients: a systematic review," J. Cancer Metastasis Treat., vol. 5, p. 79, Dec. 2019, doi: 10.20517/2394-4722.2019.008.
  29. M. Gallo, L. Sapio, A. Spina, D. Naviglio, A. Calogero, and S. Naviglio, "Lactic dehydrogenase and cancer: an overview," Front. Biosci. (Landmark Ed.), 2015. [Online]. Available: https://article.imrpress.com/bri/Landmark/articles/pdf/Landmark4368.pdf. Accessed: Mar. 29, 2025.

Proceedings of the International Conference on Applied Innovations in IT by Anhalt University of Applied Sciences is licensed under CC BY-SA 4.0  ·  This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License

ICAIIT 2026
International Conference on Applied Innovation in IT
Navigation
Publisher
ISSN2199-8876
Publisher Edition Hochschule Anhalt
Location Anhalt University of Applied Sciences
Email leiterin.hsb@hs-anhalt.de
Phone +49 (0) 3496 67 5611
Address Building 01, Room 425
Bernburger Str. 55
D-06366 Köthen, Germany
Open Access License
CC BY-SA 4.0

All works are licensed under the Creative Commons Attribution-ShareAlike 4.0 International License (CC BY-SA 4.0), unless otherwise noted.

Published by ICAIIT in cooperation with Anhalt University of Applied Sciences.

© 2026 ICAIIT — International Conference on Applied Innovations in IT. Anhalt University of Applied Sciences, Köthen, Germany.
Visitors: site traffic counter